Antimicrobial Peptide Coated Titanium Alloy for Implants
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current biomaterials, such as titanium alloys, face challenges with uncontrollable release of antimicrobial agents and toxicity issues, leading to post-operative infections and complications in orthopedic and dental implants, as existing surface modifications fail to effectively manage bacterial adhesion and proliferation.
Innovation Solution
The use of plasma immersion ion implantation and deposition (PIII&D) and pressurized hydrothermal treatment to create a controllable antimicrobial peptide coating on titanium alloys, which inhibits microbial adhesion and proliferation while allowing biocompatibility and controlled release of antimicrobial peptides upon bacterial attachment.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antibiotic or antimicrobial peptide coating is applied to titanium alloy surface, then antimicrobial properties are improved, but the release rate becomes uncontrollable and causes toxicity to surrounding human cells
Solution Approach 1:
The patent implements a dynamic release mechanism where antimicrobial peptides are released in response to bacterial presence rather than continuous release. The system transitions from static coating to responsive release based on bacterial detection, reducing toxicity to human cells while maintaining antimicrobial effectiveness.
Solution Approach 2:
The patent changes the release parameter from continuous to controlled/batch release. By modifying the release mechanism to activate only under specific conditions (bacterial presence), the system achieves controllable release rates that prevent toxicity while maintaining antimicrobial properties.
2Reliability
If conventional antibiotic coating is used, then initial antimicrobial effect is improved, but antibiotic degrades over time leaving implant surface unprotected
Solution Approach 1:
The patent implements a self-service mechanism where the implant surface automatically detects bacterial presence and triggers peptide release without external intervention. The system monitors for contamination and activates defense only when needed, extending protection duration through on-demand release rather than relying on degrading conventional coatings.
Solution Approach 2:
The patent ensures continuous protection capability through a system that can repeatedly activate peptide release in response to bacterial presence. Unlike degrading antibiotics that lose effectiveness over time, this system maintains readiness to protect by continuously monitoring and releasing peptides when bacteria are detected.
3Reliability
If silver or copper ions are loaded on surface, then bacterial adhesion is reduced, but ions poison surrounding human cells
Solution Approach 1:
The patent uses an intermediary mechanism where antimicrobial peptides serve as mediators between the implant surface and bacteria. Instead of direct contact with toxic metal ions, the peptides act as intermediate agents that prevent bacterial adhesion while being less toxic to human cells, resolving the contradiction between effectiveness and safety.
Solution Approach 2:
The patent employs short-lived antimicrobial peptides that are released only when needed rather than permanent metal ion coatings. These peptides provide temporary but effective protection against bacterial adhesion without the cumulative toxicity issues of metal ions, allowing the system to be refreshed as needed.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The modified titanium alloys effectively resist bacterial adhesion and proliferation, maintaining biocompatibility and mechanical integrity, with a controlled release mechanism that reduces the risk of antibiotic degradation and toxicity, providing long-term infection resistance in orthopedic and dental implants.
Implementation Method 1
performing surface techniques to modify the surface of a material in order to form one or several antimicrobial layers... the surface modification techniques include PIII&D
Implementation Method 2
plasma immersion ion implantation and deposition (PIII&D)
Implementation Method 3
pressurized hydrothermal treatment
Implementation Method 4
pressurized hydrothermal treatment
Implementation Method 5
a surface layer is fabricated by using a technique for the immobilization of controllable release antimicrobial peptides
Data Source
Figure 1~2A
Figure 2B~2C
Figure 3A~3C
AI summary
This invention involves a plasma treated and controllable release antimicrobial peptide coated titanium alloy for surgical implantation, where the alloy with antimicrobial properties is fabricated using surface techniques without adversely compromising its biocompatibility and original mechanical properties. The surface techniques form antimicrobial layers on the alloy capable of resisting microbial adhesion and proliferation, while allowing mammalian cell adhesion and proliferation when the alloy is implanted to human body. In one embodiment, PIII&D is applied to incorporate ions, electrons, free radicals, atoms or molecules on a titanium alloy substrate. A pressurized hydrothermal treatment can be carried out to establish reactive functional groups for antimicrobial purpose or for connecting the substrate and external antimicrobial molecules. An outermost layer of the titanium alloy includes antibacterial peptides possessing a controllable release mechanism, and is fabricated alone or in an assembly of the aforementioned basal surface layers. The controllable release mechanism is able to withstand long-term deep tissue infection after surgery, and in an embodiment comprises APTES as a linker molecule.